Isonics CEO James E. Alexander to Provide Corporate Business Overview

    Business Editors

    GOLDEN, Colo.--(BUSINESS WIRE)--April 18, 2005--Isonics Corporation (NASDAQ:ISON), committed to the development of next-generation technology for the homeland security market, has announced that CEO James E. Alexander will open the Company's annual shareholders meeting with an address that outlines achievements and activities during the past year, and offers projections for progress in the coming year.
    In his address to shareholders, Mr. Alexander will discuss activities in the Company's Life Sciences, Semiconductors, and Homeland Security divisions. He will discuss past performance of the Company's three operational segments, as well as Management's strategies and initiatives for future business development and opportunities within each division.
    "I am looking forward to meeting with shareholders tomorrow at our annual meeting," said Mr. Alexander. "Isonics commenced a particularly bold course of action in the last year that has successfully enabled us to redefine and significantly enlarge the scope of our Company. In addition to continued activities within our Life Sciences and Semiconductor operations (both of which continue to face operating challenges), during the past year we established the new Isonics Homeland Security and Defense Corporation. Creating this new division has helped us focus our resources in the development of technologies and products in the fast-growing, multi-billion-dollar worldwide security marketplace, opening up many new possibilities for Isonics."
    Mr. Alexander will elaborate on significant technologies, products and initiatives and past performance in the Company's three segments. He'll also provide an update for shareholders on the status of previously announced company acquisitions within the Homeland Security and Defense division, and will detail some of the new technologies and products these acquisitions will bring Isonics.
    "While we still continue to face operating challenges in a couple of our divisions, we have successfully moved the Company into position to build a multi-dimensional, innovative technology organization in the homeland security space, as well as our other technology sectors," said Mr. Alexander. "These measures were taken to increase revenue growth and shareholder value. We feel this is an extremely exciting time in the history of Isonics."

    About Isonics Corporation

    Isonics Corporation has three business divisions: (1) Isonics Semiconductor, (2) Isonics Life Sciences, and (3) Isonics Homeland Security and Defense. Isonics is a world leader in isotopically engineered materials and through its semiconductor division produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. Isonics' Life Sciences division markets and sells isotopes to the health care industry for the imaging and treatment of cancer. Stable isotopes can be thought of as ultra pure materials. This high degree of purification provides enhanced properties as compared to natural materials. Our efforts in the Homeland Security segment are nascent at the present time as we proceed to develop further our neutron-based detection technologies. Additional information may be obtained at the Company's Web site at http://www.isonics.com. For more investor-specific information, including daily and historical Company stock quote data and recent news releases, please visit http://www.trilogy-capital.com/tcp/isonics. To read or download the Company's Investor Fact Sheet visit http://www.trilogy-capital.com/tcp/isonics/factsheet.html. A presentation about Isonics' NeutroTest(TM) explosive detection prototype can be found at http://www.trilogy-capital.com/tcp/isonics/presentation.html. A video demonstrating the functioning NeutroTest prototype can be viewed at http://www.trilogy-capital.com/tcp/isonics/video.html.

    Cautionary Statement

    Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, and its quarterly report on Form 10-QSB for the nine months ended January 31, 2005, both as filed with the Securities and Exchange Commission, which include the Company's historical cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. Isonics cautions investors that there are currently no commercial NeutroTest products, and no guarantee there will be. Isonics has made no NeutroTest sales and no government agency or other person has expressed an interest in purchasing NeutroTest. There can be no assurance that Isonics will be able to manufacture the NeutroTest for the market at a cost and with capabilities that meet the needs of prospective customers.
    This announcement may contain forward-looking statements made by senior management of Isonics that involve risks and uncertainties, such as statements about plans, objectives, expectations, assumptions or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and performances, or achievements expressed or implied by the forward-looking statements. Actual future results and trends may differ materially from those made in -- or suggested by -- statements made in this announcement due to a variety of factors. Consequently, you should not place undue reliance on any forward-looking statements made in this announcement. For more information about Isonics and risks arising from investing in Isonics, you are directed to the Company's most recent Form 10-KSB filed with the Securities and Exchange Commission.

--30--SW/la*

CONTACT: Isonics Corporation James E. Alexander, 303-279-7900 or Investor Relations: Trilogy Capital Partners, Inc. Paul Karon, 800-592-6067 paul@trilogy-capital.com

KEYWORD: COLORADO INDUSTRY KEYWORD: HARDWARE AEROSPACE/DEFENSE GOVERNMENT SOURCE: Isonics Corporation

Copyright Business Wire 2005